Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

UCB Pharma (Germany) | Researchclopedia

Back to institutions

UCB Pharma (Germany)

Monheim am Rheincompany

1,107

Works

46,077

Citations

99

h-index

Top Research Topics

Spondyloarthritis Studies and Treatments Psoriasis: Treatment and Pathogenesis Epilepsy research and treatment

Top Researchers

Salvador Moncada Universidade Paulista

786 works151,249 citationsh-index: 173

Recent Research

Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non‐Biologic Treatment: Results From an Overlap Weighting Analysis in High‐Risk Patients With Axial Spondyloarthritis

Nigil Haroon,Zeynep Baskurt,et al.

20260 citations

Rheumatoid Arthritis Research and Therapies

Pharmacological Effects and Toxicity Studies

Parkinson's Disease Mechanisms and Treatments

Neuroscience and Neuropharmacology Research

Systemic Lupus Erythematosus Research

Neurological disorders and treatments

Pharmaceutical studies and practices

Myasthenia Gravis and Thymoma

Health Systems, Economic Evaluations, Quality of Life

Werner Poewe Innsbruck Medical University

1,038 works114,432 citationsh-index: 151

Paul J. Harrison Queen Elizabeth Hospital Birmingham

799 works47,699 citationsh-index: 105

Claudia Sommer Universitätsklinikum Würzburg

1,117 works45,793 citationsh-index: 107

Christian Hassager University of Copenhagen

1,021 works42,434 citationsh-index: 92

Malte Kelm Düsseldorf University Hospital

1,499 works40,052 citationsh-index: 96

Parents' Perspectives on Access to Pediatric Rare Disease Cross-Border Clinical Trials in Europe: Experiences of Language Inclusion and Preferences

Begonya Nafria,Ségolène Gaillard,et al.

20260 citations

Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies

Laure Gossec,Laura C Coates,et al.

20260 citations

Bimekizumab Safety in Patients with Psoriasis Achieving Complete Skin Clearance: 4-year Analysis from 5 Phase 3/3b Trials

Diamant Thaçi,Kenneth B. Gordon,et al.

20260 citations

Bimekizumab Remission and High Disease Control Over 4 years in Patients with Psoriasis Achieving Complete Skin Clearance at Week 16: Results from Four Phase 3 Trials

Richard B. Warren,Bruce Strober,et al.

20260 citations

PT4:04 Achievement of low disease activity and remission in patients with SLE treated with dapirolizumab pegol: updated 48-week analyses from a phase 3 trial including lower glucocorticoid dose criteria

Eric F Morand,L. M. Carter,et al.

20260 citations